Article by Gage Peake, Leafly
Despite several widely circulated media reports that the DEA is planning to effectively legalize medical cannabis this August, a DEA official said no definite decision has been made.
In an interview published earlier today by aNewDomain, DEA Staff Coordinator Russ Baer declined to confirm the original Santa Monica Observer report that the DEA will reschedule cannabis as a prescription-only Schedule II drug on Aug. 1. “We aren’t holding ourselves to any artificial timeframe,” he said.
The Observer report created a stir over the weekend, and generated many skeptics, based on the fact that staff writer Stan Greene’s story relied only on an anonymous “DEA lawyer with knowledge of the matter.”